Gene therapy safety check: researchers track hepatitis b patients years after treatment
Knowledge-focused
ENROLLING_BY_INVITATION
This study follows 45 people with chronic hepatitis B who have already received the experimental gene therapy PBGENE-HBV in an earlier trial. Researchers will monitor them for delayed side effects over time. No new treatment is given; the goal is to understand the long-term safet…
Sponsor: Precision BioSciences, Inc. • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:02 UTC